Reuters logo
BRIEF-Herantis Pharma ‍plans a directed share issue
October 19, 2017 / 1:13 PM / in 2 months

BRIEF-Herantis Pharma ‍plans a directed share issue

Oct 19 (Reuters) - HERANTIS PHARMA OYJ:

* ‍PLANS A DIRECTED SHARE ISSUE TO A LIMITED NUMBER OF INVESTORS AND COMPANY‘S DIRECTORS​

* ISSUE ‍REGARDS FINANCING OF LYMFACTIN PHASE 2 CLINICAL STUDY​

* ‍POSSIBLE SHARE ISSUE WOULD SEEK NEW EQUITY FINANCING IN AN AMOUNT OF APPROXIMATELY 4.6 MILLION EUROS​

* ‍SHARE ISSUE OF UP TO 800,000 SHARES​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below